St John's wort (Hypericum perforatum): drug interactions and clinical outcomes. - Wikidata - wikimedia - TriplyDB

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

http://www.wikidata.org/entity/Q34976869

about

Neuroprotective Activity of Hypericum perforatum and Its Major Components The globalization of traditional medicine in northern peru: from shamanism to molecules.Drug-drug interactions during antiviral therapy for chronic hepatitis C Treatment of premenstrual dysphoric disorder Clinically relevant safety issues associated with St. John's wort product labels.Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.Factors associated with potential medication-herb/natural product interactions in a rural community.Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions.The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products.Drug-drug interactions between warfarin and psychotropics: updated review of the literature.Herbal product-drug interactions mediated by induction.Warfarin and its interactions with foods, herbs and other dietary supplements.NCOA6 differentially regulates the expression of the CYP2C9 and CYP3A4 genes Perioperative use of herbal, complementary, and over the counter medicines in plastic surgery patients Evaluation of the light-sensitive cytotoxicity of Hypericum perforatum extracts, fractions, and pure compounds.Plant-derived natural medicines for the management of depression: an overview of mechanisms of action.Interaction of St John's wort with conventional drugs: systematic review of clinical trials.Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial.Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects Undeclared exposure to St. John's Wort in hospitalized patients Health professionals rarely record history of complementary and alternative medicines.The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials.An overview of the evidence and mechanisms of herb-drug interactions.Herb-drug interactions: an overview of the clinical evidence.Natural health product interactions with medication.Does St. John's Wort cause regression in gastrointestinal system adenocarcinomas?Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries.Nuclear receptor coactivator 6 mediates the synergistic activation of human cytochrome P-450 2C9 by the constitutive androstane receptor and hepatic nuclear factor-4alpha Herbal remedies affecting coagulation: a review.Drug interactions: a primer for the gastroenterologist New oral anticoagulants in practice: pharmacological and practical considerations.Complementary and alternative medicine: risks and special considerations in pretransplant and posttransplant patients.Phytochemical constituents as future antidepressants: a comprehensive review.Use of self-chosen therapies by depressed people in primary care.Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.Life-threatening digoxin toxicity due to drug-drug interactions in an HIV-positive man.Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals.Drug safety aspects of herbal medicinal products.Studies on Pharmacokinetic Drug Interaction Potential of Vinpocetine Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS

P2860

Q26741405-C4FA4ABC-23B9-4532-9484-ECAC62AAE68C Q26830049-D4A118A2-D1E3-430E-B0F5-7F92359F4166 Q26864887-1241FA47-520B-47E8-A3C4-3C8E4C941D02 Q28300895-F9E7B0D2-2C0A-4E59-AB51-FE54A1FFD244 Q33352845-17B2F7C6-9FA1-47BA-9F35-394422E16212 Q33509452-D27BC9AF-F52F-482E-8A17-AC24E9DFC63F Q33787244-5E4999A3-1228-4F39-B54B-390B97BED787 Q34360600-881A052D-AFE9-42DE-98F3-69F696E9C6D2 Q34432298-94326232-4BE6-420C-BC3C-DAFCF95E4F53 Q34432843-C530F012-125A-4E89-84A6-4B79262EAD5B Q34530222-625D7302-457B-47AB-93EA-DB36551291AD Q34566453-4C59BACF-931F-4495-A427-F908E3DB09BC Q34852149-384D51A2-0AE0-4AFE-BFC6-5A30A1D2E46E Q34994681-36B25CF2-E03F-4DF6-AB99-C68455BA9EAC Q35012539-F7463F80-485A-4134-9D12-C4FABF927817 Q35568075-D80FEEC7-E14F-4DF9-AF7E-FB03D86817C7 Q35615173-506D90F3-109E-47DF-BF4D-5FD6FCE22095 Q35825530-32676831-2972-43A7-A305-3C0032F42EAA Q35826093-BB7EDE19-1992-435A-B5E9-2CED666B2C39 Q35826380-05D98426-17A2-412A-A60C-8D71C27B3B79 Q35826743-FC365E41-1886-497D-9D3A-B53CB2F653DD Q35827865-5B9D70F7-4EF0-45AA-95CE-6565A401F4AD Q35919968-F19363C4-8A18-45AB-9AA3-0BF16BD6E2FB Q36014951-E9455BF1-00F8-4BDD-9298-80FE5A9E2480 Q36278312-5F8AC4E2-20F3-41C5-8352-A787E526BCAE Q36280124-13FF27A1-9A46-414E-AADF-F544561646B3 Q37217878-AEEE4533-B178-4D72-A0D4-51C2A77E35C4 Q37274199-66A21E08-ACD1-4CE6-8691-7A2DBC5247DB Q37963970-B6E4A8AE-4C9E-471C-BDEC-C78DB7BAE675 Q38039067-A01C7BD5-7FE9-4168-8CB2-263055FE8076 Q38180988-320F3471-975E-4048-9FAD-858C37681245 Q38202901-06E89A47-051F-4648-BF1D-C514B259D8FC Q38543037-CE48EDC7-9F84-4F82-BFD6-E8B534E82DC8 Q38573472-BA78CF21-6EE9-41BF-83CF-8AA15298DE5E Q38574619-331632DF-F791-4696-BA32-74573BD93222 Q38839462-019BD81C-2826-456D-A161-7ED9DF72FA0C Q40283529-84B10AD8-3502-485E-9A64-A2C0AF07E752 Q40727097-A39E2C8C-9FD1-404B-B57C-710AE4A2BAF1 Q41167581-CFD32BB3-70CD-49DD-96C6-35958CCD08A9 Q41487258-F6FC258C-1A8D-4D4D-B397-CB8A3C35938D

P2860

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

http://www.wikidata.org/entity/Q34976869

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

@ast

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

@en

type

label

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

@ast

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

@en

prefLabel

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

@ast

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

@en

P1433

Q34976869-55D9EBF9-017A-4274-90D9-605D5E2584F2

P1476

Q34976869-EAE6B617-B63E-4B05-8AC3-5B6C99496206

P2093

Q34976869-294EB3EC-2F99-44FE-A923-028DCBECB2C6

Q34976869-85463B67-E45C-4A70-9ADA-8E772DA1F4AF

Q34976869-BCA5CDD9-4A94-4746-9171-90EDEF1E07B5

Q34976869-DD80AFAC-3C9A-49C2-B8CB-4CF89C911CE3

Q34976869-EC96658E-5397-4A5C-89C8-CB140AA70F89

P2860

Q34976869-12C8F2E0-A7B8-4273-BE09-D706FF1E729B

Q34976869-1C35D4B8-65A4-4C7F-8E1D-3855FDDB2CE6

Q34976869-24C90AD8-3099-4FFE-925A-B5C2EB87680A

Q34976869-26F9A03E-A75C-4E1D-B3DF-562DC7622906

Q34976869-32475BDE-E5FF-402B-9D9B-9A0ACCFD884F

Q34976869-3B5ADEA7-E720-4474-8416-FD5972B62A6D

Q34976869-47437D3B-68BA-43EF-AF11-78A391625812

Q34976869-7B5C8039-96B1-4201-ACEC-05BBC8CF820F

Q34976869-8174BB85-4D10-4853-A777-81B65380B9E4

Q34976869-90905343-7F12-4FF4-9C07-0582E958D955

P304

Q34976869-29C5F407-B8A2-4AD6-8B9D-7F76225F369A

P31

Q34976869-37C76CA4-C25A-482A-A120-0D3A1C3A8621

P356

Q34976869-AA389AD3-A930-4690-B73F-07AC0684D5E7

P407

Q34976869-BA9B3EFA-75E2-412C-BD8A-9BF8155F2157

P433

Q34976869-AB10E554-3E13-415C-AE5F-7C1B3C985543

P478

Q34976869-49A431BB-D5AB-4047-91B9-D4BD0383F66B

P577

Q34976869-C5DDD816-CAA3-4843-8035-FF334431DEF9

P5875

Q34976869-65B36E10-3D04-4FEE-9914-19A30FB735C0

P698

Q34976869-69DC9AD2-5FE6-4607-A079-61428E8B1597

P921

Q34976869-A4A5D46D-40FF-4ED1-8A2B-4D77CA1B6D99

P932

Q34976869-B2C70A65-D0F9-4981-96F9-E389C1A92B0B

P356

J.1365-2125.2002.01683.X

P1433

British Journal of Clinical Pharmacology

P1476

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

@en

P2093

B Gerden

http://www.w3.org/2001/XMLSchema#string

C Bergquist

http://www.w3.org/2001/XMLSchema#string

L Henderson

http://www.w3.org/2001/XMLSchema#string

P Arlett

http://www.w3.org/2001/XMLSchema#string

Q Y Yue

http://www.w3.org/2001/XMLSchema#string

P2860

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

Metabolism of theophylline by cDNA-expressed human cytochromes P-450.

Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.).

Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies.

Metabolism of 17 alpha-ethynylestradiol in humans.

The role of cytochromes P-450 in cyclosporine metabolism.

Hypericin and its photodynamic action.

P304

349-356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2125.2002.01683.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11069378

http://www.w3.org/2001/XMLSchema#string

P698

12392581

http://www.w3.org/2001/XMLSchema#string

P921

Hypericum perforatum

P932

1874438

http://www.w3.org/2001/XMLSchema#string